2012 annual financial data
Innate Pharma 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -3,386,000 EUR and net income was -3,199,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,377,000 EUR
- Operating income
- -3,386,000 EUR
- Net income
- -3,199,000 EUR
- Operating cash flow
- Not available